VIPAS39 Gene Arthrogryposis Renal Dysfunction and Cholestasis Type 2 Genetic Test sale cost 4400 AED
Atypical Hemolytic Uremic Syndrome Panel NGS Genetic Test sale cost 4400 AED Atypical Hemolytic Uremic Syndrome Panel NGS Genetic Test 6,000 د.إ Original price was: 6,000 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
BBS12 Gene Bardet-Biedl Syndrome Type 12 Genetic Test sale cost 4400 AED BBS12 Gene Bardet-Biedl Syndrome Type 12 Genetic Test 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

VIPAS39 Gene Arthrogryposis Renal Dysfunction and Cholestasis Type 2 Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The VIPAS39 gene plays a crucial role in the development and function of various body systems. Mutations in this gene are associated with Arthrogryposis-Renal Dysfunction-Cholestasis (ARC) syndrome type 2, a rare genetic disorder. This condition is characterized by joint contractures (arthrogryposis), kidney dysfunction (renal dysfunction), and impaired bile flow from the liver (cholestasis), among other symptoms. Due to the complexity and rarity of ARC syndrome, accurate diagnosis is crucial for appropriate management and treatment.

DNA Labs UAE offers a specialized genetic test targeting the VIPAS39 gene to diagnose Arthrogryposis-Renal Dysfunction-Cholestasis Type 2. The test involves analyzing the patient’s DNA to identify mutations in the VIPAS39 gene that are indicative of the syndrome. This genetic test is a vital tool for confirming the diagnosis, which can significantly impact treatment decisions and genetic counseling.

The cost of the VIPAS39 gene test at DNA Labs UAE is 4400 AED. This investment includes the collection of a DNA sample, usually through a blood draw or cheek swab, and comprehensive analysis by the laboratory. Given the specialized nature of this test and the expertise required to interpret the results accurately, the cost reflects the value of providing a definitive diagnosis for affected individuals and their families.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

VIPAS39 Gene Arthrogryposis Renal Dysfunction and Cholestasis Type 2 Genetic Test

At DNA Labs UAE, we offer the VIPAS39 Gene Arthrogryposis renal dysfunction and cholestasis type 2 Genetic Test. This test aims to identify any mutations or variations in the VIPAS39 gene that may be responsible for causing Arthrogryposis, renal dysfunction, and cholestasis type 2 (ARCND2).

Test Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Hepatology Nephrology Endocrinology Disorders
  • Doctor: General Physician
  • Test Department: Genetics

Pre Test Information

Prior to undergoing the VIPAS39 Gene Arthrogryposis renal dysfunction and cholestasis type 2 Genetic Test, it is important to provide the clinical history of the patient. Additionally, a Genetic Counselling session will be conducted to draw a pedigree chart of family members affected with ARCND2. This will help in understanding the inheritance pattern of the VIPAS39 gene.

Test Details

The VIPAS39 gene is associated with a rare genetic disorder called Arthrogryposis, renal dysfunction, and cholestasis type 2 (ARCND2). This disorder is characterized by multiple joint contractures (arthrogryposis), kidney dysfunction (renal dysfunction), and liver problems (cholestasis).

NGS stands for Next-Generation Sequencing, which is a high-throughput DNA sequencing technology used to analyze multiple genes simultaneously. The NGS Genetic Test for the VIPAS39 gene aims to identify any mutations or variations in the VIPAS39 gene that may be responsible for causing ARCND2.

This genetic test can help diagnose ARCND2 in individuals with symptoms suggestive of the disorder. It can also be used for carrier testing in individuals with a family history of ARCND2, as well as for prenatal testing in families with a known VIPAS39 gene mutation.

The results of the NGS Genetic Test for the VIPAS39 gene can provide valuable information for clinical management, genetic counseling, and potentially guide treatment options for individuals affected by ARCND2. It is important to consult with a healthcare professional or genetic counselor to understand the implications of the test results and to discuss appropriate management strategies.

Test Name VIPAS39 Gene Arthrogryposis renal dysfunction and cholestasis type 2 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Hepatology Nephrology Endocrinology Disorders
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for VIPAS39 Gene Arthrogryposis, renal dysfunction, and cholestasis type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with VIPAS39 Gene Arthrogryposis, renal dysfunction, and cholestasis type 2 NGS Genetic DNA Test gene VIPAS39
Test Details

The VIPAS39 gene is associated with a rare genetic disorder called Arthrogryposis, renal dysfunction, and cholestasis type 2 (ARCND2). This disorder is characterized by multiple joint contractures (arthrogryposis), kidney dysfunction (renal dysfunction), and liver problems (cholestasis).

NGS stands for Next-Generation Sequencing, which is a high-throughput DNA sequencing technology used to analyze multiple genes simultaneously. The NGS Genetic Test for VIPAS39 gene aims to identify any mutations or variations in the VIPAS39 gene that may be responsible for causing ARCND2.

By analyzing the VIPAS39 gene, this genetic test can help diagnose ARCND2 in individuals with symptoms suggestive of the disorder. It can also be used for carrier testing in individuals with a family history of ARCND2, as well as for prenatal testing in families with a known VIPAS39 gene mutation.

The results of the NGS Genetic Test for VIPAS39 gene can provide valuable information for clinical management, genetic counseling, and potentially guide treatment options for individuals affected by ARCND2. It is important to consult with a healthcare professional or genetic counselor to understand the implications of the test results and to discuss appropriate management strategies.

SKU: TEST-3567 Category:

Related products